1. Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial. Issue 12 (December 2021) Authors: Marconi, Vincent C; Ramanan, Athimalaipet V; de Bono, Stephanie; Kartman, Cynthia E; Krishnan, Venkatesh; Liao, Ran; Piruzeli, Maria Lucia B; Goldman, Jason D; Alatorre-Alexander, Jorge; de Cassia Pellegrini, Rita; Estrada, Vicente; Som, Mousumi; Cardoso, Anabela; Chakladar, Sujatro; Crowe, Brend... Journal: Lancet Issue: Volume 9:Issue 12(2021) Page Start: 1407 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗